BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12514704)

  • 1. NCI to focus on clinical trial speed.
    Novak K
    Nat Med; 2003 Jan; 9(1):8. PubMed ID: 12514704
    [No Abstract]   [Full Text] [Related]  

  • 2. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/ TRICARE; coverage of phase II and phase III clinical trials sponsored by the National Institutes of Health National Cancer Institute. Final rule.
    Office of the Secretary, DoD
    Fed Regist; 2006 Jun; 71(118):35389-91. PubMed ID: 16795948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization, more funds on horizon for clinical trials.
    McNeil C
    J Natl Cancer Inst; 2005 Apr; 97(8):555-7. PubMed ID: 15840874
    [No Abstract]   [Full Text] [Related]  

  • 4. Barriers to clinical trial enrollment: are state mandates the solution?
    Hillner BE
    J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
    [No Abstract]   [Full Text] [Related]  

  • 5. NCI seeks more patients for trials.
    Zoler ML
    Med World News; 1988 Jun; 29(12):23. PubMed ID: 10287972
    [No Abstract]   [Full Text] [Related]  

  • 6. Who should subsidize NCI clinical trials?
    Ault A
    Nat Med; 1998 Sep; 4(9):992. PubMed ID: 9734381
    [No Abstract]   [Full Text] [Related]  

  • 7. The NCI program of therapeutic research.
    Simon R
    Bull Cancer; 1991; 78(12):1105-8. PubMed ID: 1786423
    [No Abstract]   [Full Text] [Related]  

  • 8. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); methodology for coverage of phase II and phase III clinical trials sponsored by the National Institutes of Health. Office of the Secretary; DoD. Final rule.
    Fed Regist; 2001 Jan; 66(21):8365-6. PubMed ID: 11503809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical research. Testing a novel strategy against Parkinson's disease.
    Couzin J
    Science; 2007 Mar; 315(5820):1778. PubMed ID: 17395800
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial registration.
    Brubaker L
    Neurourol Urodyn; 2007; 26(2):147. PubMed ID: 17354253
    [No Abstract]   [Full Text] [Related]  

  • 11. Cooperative groups say NCI trials funding inadequate; some turn to industry.
    Schmidt C
    J Natl Cancer Inst; 2007 Jun; 99(11):830-1, 837. PubMed ID: 17551138
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials Referral Resource. Clinical trials at the medicine branch of the NCI--Part I.
    Cheson BD; Wittes RE; Phillips PH
    Oncology (Williston Park); 1995 Apr; 9(4):292-4. PubMed ID: 7547193
    [No Abstract]   [Full Text] [Related]  

  • 13. NCI mounts campaign to increase number of patients in clinical trials.
    Oncology (Williston Park); 1988 Sep; 2(9):50, 53, 57. PubMed ID: 3275067
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCI begins overhaul of late-stage cancer trials.
    Ault A
    Nat Med; 1998 Nov; 4(11):1219. PubMed ID: 9809532
    [No Abstract]   [Full Text] [Related]  

  • 16. Gore champions major new cancer initiative.
    Castellucci L
    J Natl Cancer Inst; 1998 Feb; 90(4):270. PubMed ID: 9486811
    [No Abstract]   [Full Text] [Related]  

  • 17. Test panels no better than internal review.
    Dickey C
    Nat Med; 2003 Jan; 9(1):7-8. PubMed ID: 12514702
    [No Abstract]   [Full Text] [Related]  

  • 18. NCI seeks partnership with HMOs.
    Kertesz L
    Mod Healthc; 1996 Jun; 26(26):12. PubMed ID: 10158321
    [No Abstract]   [Full Text] [Related]  

  • 19. NIH institute to work with trial of AIDS vaccine, despite concerns.
    Wadman M
    Nature; 1998 Aug; 394(6696):818. PubMed ID: 9732856
    [No Abstract]   [Full Text] [Related]  

  • 20. What is the appropriate role of the trial statistician in preparing and presenting interim findings to an independent Data Monitoring Committee in the U.S. Cancer Cooperative Group setting?
    Bryant J
    Stat Med; 2004 May; 23(10):1507-11. PubMed ID: 15122728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.